Investor List:

Top Pharmaceuticals Pre-Seed Investors in Midwest (10)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Dipa Talati Mehta, Managing Director at BlueCross BlueShield Venture Partners
Dipa Talati Mehta
Sweet spot: $1M
Range: $1M - $20.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in BioTech, Investors in Consumer Internet, Investors in Consumer Internet, Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Erik Berg, Analyst at Rev1 Ventures
Erik Berg
Rev1 Ventures·Analyst
Sweet spot: $240K
Range: $150K - $325K
Investors in Columbus (OH), Investors in Cleveland (OH)
Investors in AgTech, Investors in AgTech, Investors in Developer Tools, Investors in Developer Tools, Investors in FinTech, Investors in FinTech, Investors in Food and Beverage, Investors in Food and Beverage, Investors in Health IT, Investors in Health IT, Investors in Insurance, Investors in Insurance, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in SaaS, Investors in SaaS, Investors in Web3/Blockchain, Investors in Web3/Blockchain
Photo of Noah Berkson, Managing Partner at Candor Ventures
Noah Berkson
Candor Ventures·Managing Partner
Sweet spot: $200K
Range: $100K - $750K
Investors in Los Angeles (CA), Investors in Chicago (IL), Investors in Miami (FL), Investors in London
Investors in AgTech, Investors in AgTech, Investors in FinTech, Investors in FinTech, Investors in Human Capital/HRTech, Investors in Human Capital/HRTech, Investors in Insurance, Investors in Insurance, Investors in Los Angeles / Southern California (Other Lists), Investors in Marketplaces, Investors in Marketplaces, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in Real Estate/PropTech, Investors in Real Estate/PropTech, Investors in SaaS, Investors in SaaS, Investors in Sales & CRM, Investors in Sales & CRM, Investors in Investors who invested in diverse founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of Niall O’Donnell, Managing Director at RiverVest
Niall O’Donnell
RiverVest·Managing Director
Sweet spot: $100K
Range: $100K - $1M
Investors in San Diego (CA), Investors in St. Louis (MO)
Investors in BioTech, Investors in BioTech, Investors in Enterprise, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Los Angeles / Southern California (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Derek Rapp, Managing Director at RiverVest
Derek Rapp
RiverVest·Managing Director
Sweet spot: $100K
Range: $100K - $1M
Investors in St. Louis (MO)
Investors in BioTech, Investors in BioTech, Investors in Enterprise, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Midwest (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Jay Schmelter, Managing Director at RiverVest
Jay Schmelter
RiverVest·Managing Director
Sweet spot: $1M
Range: $100K - $10.0M
Investors in St. Louis (MO)
Investors in BioTech, Investors in BioTech, Investors in Enterprise, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of John McKearn, Managing Director at RiverVest
John McKearn
RiverVest·Managing Director
Sweet spot: $1M
Range: $100K - $10.0M
Investors in Cleveland (OH), Investors in San Diego (CA), Investors in St. Louis (MO)
Investors in BioTech, Investors in BioTech, Investors in Enterprise, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Phil Hagerman, Partner at Comeback Capital
Phil Hagerman
Sweet spot: $150K
Range: $50K - $250K
Investors in Flint (MI)
Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Midwest (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Get new data & insights delivered to your inbox